This short report describes a case of drug induced parkinsonism associated with the use of sodium valproate therapy as a mood stabiliser. The clinical utility of FP-CIT SPECT scanning in the differential diagnosis of parkinsonism and tremor disorders is briefly reviewed. The importance of early recognition of valproate-induced parkinsonism is emphasised since this clinical syndrome is largely reversible after drug withdrawal.
Get full access to this article
View all access options for this article.
References
1.
ArmonCCShinMillerP Reversible parkinsonism and cognitive impairment with chronic valproate use. Neurology 1996; 47:626–35.
2.
EasterfordKPCloughKellettM Reversible parkinsonism with normal Beta- CIT SPECT in patients exposed to sodium valproate. Neurology 2004; 62:1435–7
3.
BenamerHTSJPattersonDGGrosset and (123 I) FP-CIT Study Group. Accurate differentiation of parkinsonism and essential tremor using visual assessment of 123 I FP-CIT SPECT imaging. Mov Disord 2000; 15:503–10.
4.
BooijJJDSpeilmanMIMHorstink,Wolters SEC. The clinical benefit of imaging striatal dopamine transporters with 123 I FPCIT SPECT in differentiating patients with presynaptic parkinsonism from those with others forms of parkinsonism. Eur J Nucl Med 2001; 28:266–72.
5.
TolosaEStudyCUPS Group. Accuracy of 123 I – ioflupane (DaT SCAN) in the diagnosis of patients with clinically uncertain parkinsonism: A two year follow-up study. Mov Disord 2005; 20 (Suppl 10):S40; 136.
6.
OwensMJNemeroffCB.Pharmacology of valproate Psychopharmacol Bull 2003; 37(Suppl 2):17–24.
